- Home
- HMST vs CDXS Comparison
HMST vs CDXS Comparison
Compare HMST & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- CDXS
- Stock Information
- Founded
- HMST 1921
- CDXS 2002
- Country
- HMST United States
- CDXS United States
- Employees
- HMST N/A
- CDXS N/A
- Industry
- HMST Major Banks
- CDXS Major Chemicals
- Sector
- HMST Finance
- CDXS Industrials
- Exchange
- HMST Nasdaq
- CDXS Nasdaq
- Market Cap
- HMST 249.4M
- CDXS 254.3M
- IPO Year
- HMST 2012
- CDXS 2010
- Fundamental
- Price
- HMST $12.91
- CDXS $2.69
- Analyst Decision
- HMST Hold
- CDXS Buy
- Analyst Count
- HMST 3
- CDXS 2
- Target Price
- HMST $14.17
- CDXS $11.00
- AVG Volume (30 Days)
- HMST 67.4K
- CDXS 819.6K
- Earning Date
- HMST 07-28-2025
- CDXS 08-11-2025
- Dividend Yield
- HMST N/A
- CDXS N/A
- EPS Growth
- HMST N/A
- CDXS N/A
- EPS
- HMST N/A
- CDXS N/A
- Revenue
- HMST $78,496,000.00
- CDXS $49,815,000.00
- Revenue This Year
- HMST $161.80
- CDXS $12.53
- Revenue Next Year
- HMST $8.90
- CDXS $22.54
- P/E Ratio
- HMST N/A
- CDXS N/A
- Revenue Growth
- HMST N/A
- CDXS N/A
- 52 Week Low
- HMST $8.41
- CDXS $1.90
- 52 Week High
- HMST $16.10
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- HMST 47.50
- CDXS 45.92
- Support Level
- HMST $12.46
- CDXS $2.77
- Resistance Level
- HMST $13.83
- CDXS $3.39
- Average True Range (ATR)
- HMST 0.44
- CDXS 0.19
- MACD
- HMST -0.07
- CDXS -0.06
- Stochastic Oscillator
- HMST 32.85
- CDXS 13.58
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.